Research Alliance Corp IV (RACD) company profile
Close on Nov 17, 2026Market cap $94.17MP/E –Yield –
About Research Alliance Corp IV
Blank Checks, SIC 6770
Research Alliance Corp IV is listed on Nasdaq under the ticker RACD, in the SEC industry Blank Checks. It is incorporated in E9 and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- Research Alliance Corp IV
- Headquarters
- New York, NY
- Address
- 600 Fifth Avenue, 23rd Floor 10020
- Phone
- (617) 778-2500
- Industry
- Blank Checks
- Incorporated in
- E9
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- RACD
- Exchange
- Nasdaq
- IPO date
- Jul 13, 2026
- Shares outstanding
- 9M, Aug 19, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2137777
- CUSIP
- G75228109
- FIGI
- BBG022WBPDW2
- Share class FIGI
- BBG022WBPFT1
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Matthew Hammond | Chief Executive Officer, Director | 275,000 |
| Henry William Stusnick | COO and CBO | – |
| Francis Sherman Adams | Chief Financial Officer | – |
| Alliance Holdings IV LLC Research | Director | 275,000 |
| Alan A. Musso | Director | – |
| John Michael Maslowski | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Jul 13, 2026
- Offer price
- $10.00
- Exchange
- Nasdaq
- First trading day
- Jul 13, 2026
- First-day close
- $10.34+3.4%
- Lock-up ends (est.)
- Jan 9, 2027
“This is an initial public offering of our Class A ordinary shares, par value $0.0001 per share, which we refer to as our public shares, at an initial public offering price per share of $10.00.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 13, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 10, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?